Stock GILD GILEAD SCIENCES, INC.
Add to a list
To use this feature you must be a member
Log inSign up
PDF Report : Gilead Sciences, Inc.

Calendar Gilead Sciences, Inc.

Equities

GILD

US3755581036

Market Closed - Nasdaq
Other stock markets
 04:00:00 2023-12-06 pm EST 		Intraday chart for Gilead Sciences, Inc. 5-day change 1st Jan Change
79.36 USD +0.43% +5.49% -7.56%
Dec. 06 Transgene: new CFO, share price rises CF
Dec. 04 IDEAYA Biosciences Collaborates With Gilead Sciences to Evaluate Combination of Trodelvy, IDE397 for Bladder Cancer MT

Chart calendar Gilead Sciences, Inc.

b54f721625b86958c42029.dU3nPGRbbIqPokgNbY6g2kKUkzhpCHE4eyd6UFL5GXE.Ex6fXQc6XufNxSBePvfK6Rbz51JcbhJgA1cbFgKIURkDPpR5EApb0sH3fA~08c9243633df637b16bf82e1fcd68547

Upcoming events on Gilead Sciences, Inc.

2023-12-08 01:00 pm San Antonio Breast Cancer Symposium - Poster No: PO5-21-09
2023-12-08 American Society of Hematology Meeting - Abstract Number : 6899
2023-12-08 American Society of Hematology Meeting - Abstract Number : 6126
2023-12-09 12:30 pm American Society of Hematology Meeting - Abstract Number : 103
2023-12-09 01:15 pm American Society of Hematology Meeting - Abstract Number : 106
2023-12-09 01:30 pm American Society of Hematology Meeting - Abstract Number : 107
2023-12-09 05:00 pm American Society of Hematology Meeting - Abstract Number : 223
2023-12-09 05:15 pm American Society of Hematology Meeting - Abstract Number : 224
2023-12-09 05:45 pm American Society of Hematology Meeting - Abstract Number : 224
2023-12-09 05:45 pm American Society of Hematology Meeting - Abstract Number : 226
2023-12-09 08:30 pm American Society of Hematology Meeting - Abstract Number : 2121
2023-12-09 08:30 pm American Society of Hematology Meeting - Abstract Number : 1761
2023-12-09 08:30 pm American Society of Hematology Meeting - Abstract Number : 2336
2023-12-09 08:30 pm American Society of Hematology Meeting - Abstract Number : 1638
2023-12-09 08:30 pm American Society of Hematology Meeting - Abstract Number : 2434

Past events on Gilead Sciences, Inc.

Today 06:00 pm San Antonio Breast Cancer Symposium - Poster No: PO2-05-02
Today 06:00 pm San Antonio Breast Cancer Symposium - Poster No: PO2-05-03
2023-12-06 01:00 pm San Antonio Breast Cancer Symposium - Poster No: PO1-06-10
2023-12-06 01:00 pm San Antonio Breast Cancer Symposium - Poster No: PO1-10-06
2023-12-06 01:00 pm San Antonio Breast Cancer Symposium - Poster No.: PO1-06-08
2023-12-06 01:00 pm San Antonio Breast Cancer Symposium - Poster No.: PO1-04-06
2023-12-06 01:00 pm San Antonio Breast Cancer Symposium - Poster No.: PO1-05-09
2023-11-29 09:00 am Piper Sandler Healthcare Conference
2023-11-28 01:20 pm Evercore ISI HealthCONx Conference
2023-11-15 04:00 am Jefferies London Healthcare Conference
2023-11-09 American Association for the Study of Liver Diseases Conference - Poster 1817-A
2023-11-09 American Association for the Study of Liver Diseases Conference - Poster 1881-A
2023-11-09 American Association for the Study of Liver Diseases Conference - Poster 1429-C
2023-11-09 American Association for the Study of Liver Diseases Conference - Poster 1414-C
2023-11-09 American Association for the Study of Liver Diseases Conference - Poster 1430-C
2023-11-09 American Association for the Study of Liver Diseases Conference - Poster 1422-C
2023-11-09 American Association for the Study of Liver Diseases Conference - Poster 1233-C
2023-11-09 American Association for the Study of Liver Diseases Conference - Poster 4533-C
2023-11-09 American Association for the Study of Liver Diseases Conference - Poster 2059-A
2023-11-09 American Association for the Study of Liver Diseases Conference - Poster 1904-A

Past dividends on Gilead Sciences, Inc.

2023-09-13 Quarterly 0.75 USD
2023-06-13 Quarterly 0.75 USD
2023-03-13 Quarterly 0.75 USD
2022-12-13 Quarterly 0.73 USD
2022-09-13 Quarterly 0.73 USD
2022-06-13 Quarterly 0.73 USD
2022-03-13 Quarterly 0.73 USD
2021-12-13 Quarterly 0.71 USD
2021-09-13 Quarterly 0.71 USD
2021-06-13 Quarterly 0.71 USD

Annual results

Fiscal PeriodDecember 2018 2019 2020 2021 2022 2023
Net sales
Million USD		Released
Forecast
Spread 		22 127
21 839
1.32%		22 449
22 305
0.65%		24 689
24 482
0.84%		27 305
26 657
2.43%		27 281
26 518
2.88%
27 053

EBITDA
Million USD		Released
Forecast
Spread 		12 840
12 564
2.2%		12 468
13 029
-4.3%		13 184
13 142
0.32%		14 598
15 539
-6.05%		14 283
13 783
3.63%
13 071

EBIT
Million USD		Released
Forecast
Spread 		11 411
11 753
-2.91%		11 064
11 571
-4.38%		11 704
11 599
0.9%		12 548
13 943
-10.01%		12 180
12 141
0.32%
10 721

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		7 799
9 060
-13.92%		5 160
5 333
-3.24%		1 669
1 636
2.01%		8 278
9 507
-12.92%		5 814
5 658
2.76%
7 328

Net income
Million USD		Released
Forecast
Spread 		5 455
7 207
-24.31%		5 386
4 292
25.5%		123
137
-10.03%		6 225
7 205
-13.6%		4 592
4 383
4.77%
5 887

EPS
USD		Released
Forecast
Spread 		4,17
5,47
-23.75%		4,22
3,43
23.14%		0,10
0,12
-16.23%		4,93
5,75
-14.19%		3,64
3,48
4.75%
4,70

Announcement Date04/02/1904/02/2004/02/2101/02/2202/02/23-

Quarterly results

Fiscal PeriodDecember 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Million USD		Released
Forecast
Spread 		7 421
6 333
17.18%		7 244
6 615
9.51%		6 590
6 279
4.96%		6 260
5 873
6.6%		7 042
6 133
14.82%		7 389
6 630
11.45%		6 352
6 326
0.41%		6 599
6 454
2.24%		7 051
6 800
3.69%
7 071


6 478


6 823


7 066


7 329

EBITDA
Million USD		Released
Forecast
Spread 		4 902
3 922
24.98%		2 042
3 449
-40.79%		4 049
3 438
17.79%		3 195
3 183
0.38%		3 811
3 049
24.99%		3 227
2 865
12.63%		2 883
3 407
-15.38%		3 258
3 343
-2.54%		3 908
3 636
7.49%
3 558













EBIT
Million USD		Released
Forecast
Spread 		4 379
3 126
40.09%		1 507
2 905
-48.13%		3 524
3 060
15.15%		2 670
2 602
2.6%		3 286
2 529
29.91%		2 699
2 622
2.92%		2 243
2 658
-15.62%		2 277
2 776
-17.99%		3 224
3 060
5.37%
2 964


2 959


3 056


3 327


3 018

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		3 438
1 953
76.07%		759
1 966
-61.4%		-152
2 158
-107.05%		1 503
1 664
-9.68%		2 432
1 674
45.28%		2 031
1 840
10.37%		1 300
1 900
-31.59%		1 588
1 969
-19.35%		2 318
2 275
1.91%
2 090


2 094


1 914


2 315


2 218

Net income
Million USD		Released
Forecast
Spread 		2 592
1 769
46.54%		382
1 424
-73.17%		19,0
1 611
-98.82%		1 144
1 367
-16.32%		1 789
1 248
43.39%		1 640
1 438
14.02%		1 010
1 587
-36.37%		1 045
1 545
-32.38%		2 180
1 801
21.07%
1 629


1 565


1 660


1 878


2 011

EPS
USD		Released
Forecast
Spread 		2,05
1,37
49.99%		0,30
1,14
-73.64%		0,02
1,34
-98.5%		0,91
1,11
-17.89%		1,42
1,01
40.93%		1,30
1,15
13%		0,80
1,23
-34.75%		0,83
1,20
-30.93%		1,73
1,43
20.88%
1,29


1,33


1,43


1,63


1,40

Announcement Date28/10/2101/02/2228/04/2202/08/2227/10/2202/02/2327/04/2303/08/2307/11/23-----

Upcoming sector events for Gilead Sciences, Inc.

2024-01-07 Q2 2024 Earnings Release (Projected)
2024-01-10 Q3 2023 Earnings Release
2024-01-22 Q3 2024 Earnings Release (Projected)
2024-01-23 06:20 am Q4 2023 Earnings Release
2024-01-24 Q3 2023 Earnings Release (Projected)
2024-01-25 Q4 2023 Earnings Release (Projected)
2024-01-25 Q3 2024 Earnings Release (Projected)
2024-01-28 Q3 2024 Earnings Release (Projected)
2024-01-28 Q3 2023 Earnings Release (Projected)
2024-01-29 Q4 2023 Earnings Release (Projected)
More events

Past sector events for Gilead Sciences, Inc.

2023-11-29 Q3 2023 Earnings Release
2023-11-27 Q2 2024 Earnings Release
2023-11-16 01:37 am Q3 2023 Earnings Release
2023-11-15 07:30 am Q3 2023 Earnings Release
2023-11-15 06:59 am Q1 2024 Earnings Release
2023-11-15 01:30 am Q3 2023 Earnings Release
2023-11-15 01:30 am Q3 2023 Earnings Release
2023-11-14 03:44 am Q2 2024 Earnings Release
2023-11-13 Q3 2023 Earnings Release
2023-11-13 07:00 am Q2 2023 Earnings Release

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock
  2. Equities
  3. Stock Gilead Sciences, Inc. - Nasdaq
  4. Calendar Gilead Sciences, Inc.
The best tools reserved for subscribers to boost the performance of your investments!
Optimize my profits
fermer